
NYSEHealthcareMedical - Healthcare Information Services
最新資料
US$4.04
+US$0.08 · +2.02%
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
前收盤價
US$4.04
+US$0.08 · +2.02%
盤中時間採用ET。市場資料可能有所延遲。
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
日內區間
目前US$4.04
52週區間
目前US$4.04
盤中時間採用ET。市場資料可能有所延遲。
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
日內區間
目前US$4.04
52週區間
目前US$4.04
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 18.76億 USD | 25.55億 USD | 19.64億 USD | 13.52億 USD | 9.08億 USD |
| 銷貨成本 | 15.92億 USD | 21.87億 USD | 15.03億 USD | 10.35億 USD | 6.58億 USD |
| 毛利 | 2.84億 USD | 3.67億 USD | 4.6億 USD | 3.17億 USD | 2.5億 USD |
| 研究與開發 | — | — | — | 2700萬 USD | — |
| 銷售、一般及管理費用 | 2.88億 USD | 2.63億 USD | 3.58億 USD | 2.69億 USD | 2.19億 USD |
| 營業費用 | 2.88億 USD | 4.08億 USD | 5.32億 USD | 3.13億 USD | 2.93億 USD |
| 利息收入 | 419萬 USD | 554.4萬 USD | 525.6萬 USD | 136.9萬 USD | 40.7萬 USD |
| 利息支出 | 5747.1萬 USD | 2472.2萬 USD | 5420.5萬 USD | 1557.2萬 USD | 2542.5萬 USD |
| 折舊和攤銷 | 1.16億 USD | 1.18億 USD | 1.23億 USD | 9025.1萬 USD | 6003.7萬 USD |
| 營業利益 | −443.5萬 USD | −4048.5萬 USD | −7121.1萬 USD | 364.2萬 USD | −4241.1萬 USD |
| 淨利 | −5.35億 USD | −6162.3萬 USD | −1.13億 USD | −1916.4萬 USD | −3760.1萬 USD |
公司資料更新於 2026年10月12日。
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$7.00
上漲空間 73.27%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1523.18萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1172.59萬0.01%787.4億 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF592.5萬0.01%954億 USD0.05%US$235+0.80%
Schwab Fundamental U.S. Small Company Index ETFFNDA452.69萬0.05%87.82億 USD0.25%US$35.62+0.17%
Janus Henderson Small/Mid Cap Growth Alpha ETFJSMD331.74萬0.32%10.5億 USD0.30%US$91.44+1.13%
Vanguard Russell 2000 ETFVTWO295.83萬0.02%180億 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA217.41萬0.01%218.24億 USD0.03%US$32.79+0.40%
Vanguard U.S. Value Factor ETFVFVA155.84萬0.18%9.57億 USD0.13%US$153.78-0.36%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Schwab Fundamental U.S. Small Company Index ETFFNDA
Janus Henderson Small/Mid Cap Growth Alpha ETFJSMD
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
Vanguard U.S. Value Factor ETFVFVAAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。